Reaction
New Onset Diabetes After Transplantation reporting signals
As of the last recalculation, New Onset Diabetes After Transplantation appears in 167 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 5,374.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus | 163 | 5,374.4 | 5,380.0 |
| Tacrolimus Ointment 0.1% | 150 | 1,465.9 | 1,467.7 |
| Tacrolimus Extended-Release Capsules | 150 | 1,462.0 | 1,463.8 |
| Anti-Thymocyte Globulin (Rabbit) | 18 | 311.6 | 312.3 |
| Mycophenolic Acid | 52 | 293.6 | 294.1 |
| Valganciclovir Hydrochloride Powder, | 24 | 286.2 | 286.8 |
| Valganciclovir | 24 | 185.1 | 185.4 |
| Valganciclovir Hydrochloride | 24 | 185.1 | 185.4 |
| Basiliximab | 11 | 124.7 | 124.8 |